Första AP-fonden’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $19.3M | Sell |
417,800
-43,800
| -9% | -$2.03M | 0.13% | 152 |
|
2025
Q1 | $28.2M | Sell |
461,600
-176,400
| -28% | -$10.8M | 0.21% | 87 |
|
2024
Q4 | $36.1M | Sell |
638,000
-11,800
| -2% | -$667K | 0.26% | 70 |
|
2024
Q3 | $33.6M | Buy |
649,800
+18,100
| +3% | +$936K | 0.26% | 72 |
|
2024
Q2 | $26.2M | Buy |
631,700
+83,300
| +15% | +$3.46M | 0.23% | 78 |
|
2024
Q1 | $29.7M | Buy |
548,400
+29,600
| +6% | +$1.61M | 0.25% | 77 |
|
2023
Q4 | $26.6M | Sell |
518,800
-56,100
| -10% | -$2.88M | 0.27% | 71 |
|
2023
Q3 | $33.4M | Sell |
574,900
-3,200
| -0.6% | -$186K | 0.37% | 48 |
|
2023
Q2 | $37M | Sell |
578,100
-24,900
| -4% | -$1.59M | 0.4% | 44 |
|
2023
Q1 | $41.8M | Sell |
603,000
-51,000
| -8% | -$3.53M | 0.49% | 36 |
|
2022
Q4 | $47.1M | Buy |
654,000
+90,300
| +16% | +$6.5M | 0.53% | 33 |
|
2022
Q3 | $40.1M | Buy |
563,700
+74,400
| +15% | +$5.29M | 0.49% | 39 |
|
2022
Q2 | $37.7M | Sell |
489,300
-10,100
| -2% | -$778K | 0.49% | 37 |
|
2022
Q1 | $36.5M | Sell |
499,400
-32,700
| -6% | -$2.39M | 0.41% | 47 |
|
2021
Q4 | $33.2M | Sell |
532,100
-18,600
| -3% | -$1.16M | 0.33% | 57 |
|
2021
Q3 | $32.6M | Buy |
550,700
+55,900
| +11% | +$3.31M | 0.37% | 52 |
|
2021
Q2 | $33.1M | Buy |
494,800
+48,900
| +11% | +$3.27M | 0.39% | 48 |
|
2021
Q1 | $28.2M | Sell |
445,900
-68,200
| -13% | -$4.31M | 0.39% | 45 |
|
2020
Q4 | $31.9M | Buy |
514,100
+84,800
| +20% | +$5.26M | 0.48% | 40 |
|
2020
Q3 | $25.9M | Buy |
429,300
+14,600
| +4% | +$880K | 0.53% | 38 |
|
2020
Q2 | $24.4M | Buy |
414,700
+72,300
| +21% | +$4.25M | 0.64% | 29 |
|
2020
Q1 | $19.1M | Buy |
+342,400
| New | +$19.1M | 0.69% | 24 |
|